Sponsor

Region Oestergoetland

Sweden Universitetssjukhuset I, 58185 Linkoping, Sweden

About the sponsor

Clinical research includes acute kidney injury after coronary artery bypass surgery, hemodialysis care, and renal and ureteral malignancies, as well as benign renal tumours, nephrolithiasis, and renal reflux. Surgical and perioperative studies also address recovery in upper urinary tract surgery and fluid management in laparoscopic surgery.

Acute kidney injury
Hemodialysis
Upper urinary tract surgery
Renal and ureteral disease

Research activity spans both operative and supportive care settings, with attention to kidney protection, urinary tract surgery, and treatment-related outcomes in renal disease.

About Specializations

Region Oestergoetland runs clinical trials in conditions such as Medical device site joint infection, Laparoscopic surgery, Glomerulonephritis chronic, Ureteric cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

9 clinical trials

Medical device site joint infection

Recruiting

Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

Registered drug

Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Saline
Sponsor:Region Oestergoetland

Contact Research Centre

Laparoscopic surgery

Recruiting

Study on the Effects of Human Albumin Solution and Electrolyte Drug Combination for Fluid Therapy in Patients Undergoing Laparoscopic Surgery

Registered drugNo placebo

Study on the Effects of Human Albumin Solution and Electrolyte Drug Combination for Fluid Therapy in Patients Undergoing Laparoscopic Surgery

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Human Albumin Solution
Sponsor:Region Oestergoetland

Contact Research Centre

Glomerulonephritis chronic

Recruiting

Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

Registered drugNo placebo

Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Rituximab
Sponsor:Region Oestergoetland

Contact Research Centre

Ureteric cancer+7

Recruiting

Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

Registered drugNo placebo

Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Anhydrous Lidocaine Hydrochloride
Sponsor:Region Oestergoetland

Contact Research Centre

Staphylococcal bacteraemia+1

Recruiting

Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo

Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Cloxacillin
Sponsor:Region Oestergoetland

Contact Research Centre

Tuberculosis

Recruiting

Study on Higher Doses of Rifampicin and Pyrazinamide for Shortened Treatment of Mild-to-Moderate Tuberculosis in Patients with Drug-Sensitive Pulmonary TB

Registered drugNo placebo